This study is intended to provide contemporary data on the residual cardiovascular risk in all consecutive patients with acute myocardial infarction, especially in patients who survived stably within one-year after percutaneous coronary intervention. In addition, this study will identify which baseline clinical, angiographic, or treatment factors are associated with residual cardiovascular risk and bleeding events
COREA-AMI registry was conducted previously (NCT02385682) and enrolled consecutive all patient with acute myocardial infarction who were treated with percutaneous coronary intervention from Jan 2004 to Dec 2009. COREA-AMI II registry extend the enrollment period to Aug 2014 and the follow-up period to Jun 2016. All consecutive acute myocardial infarction patients had been enrolled prospectively in prior registries of each university hospitals. Eight hospitals of the Catholic University of Korea already have web-based coronary intervention registry (NCT01239914). And Cheonnam University Hospital is one of leading hospitals to design and manage the web-based previous Korean nationwide myocardial infarction registry, the Korea Acute Myocardial Infarction Registry (KAMIR) (http://www.kamir.or.kr/). Using these previous data, the current registry update new clinical and angiographic variables and assess long-term clinical follow-up data retrospectively. All data were collected on web-based system after eliminating personal information. (http://www.ecrf.kr/coreaami/) All data are going to be sealed with code by Clinical Research Coordinating Center of the Catholic University of Korea and to be managed and analyzed by independent statistics perssonels. Cardiovascular center with high-volume percutaneous coronary intervention of following hospitals were participated. * Seoul St. Mary's Hospital, Seoul, South Korea * Yeoido St. Mary's Hospital, Seoul, South Korea * Uijongbu St. Mary's Hospital, Gyeonggi-do, South Korea * St. Paul Hospital, Seoul, South Korea * Bucheon St. Mary's Hospital, Gyeonggi-do, South Korea * Incheon St. Mary's Hospital, Incheon, South Korea * St. Vincent Hospital, Gyeonggi-do, South Korea * Deajon St. Mary's Hospital, Daejeon, South Korea * Cheonnam University Hospital, Gwangju, South Korea
Study Type
OBSERVATIONAL
Enrollment
13,000
Percutaneous coronary intervention
Dual AntiPlatelet Therapy
Percutaneous coronary intervention
Dual AntiPlatelet Therapy
Chonnam National University Hospital
Gwangju, South Korea
RECRUITINGSeoul St. Mary's Hospital, The Catholic University of Korea
Seoul, South Korea
RECRUITINGCumulative incidence of cardiovascular events
Cardiac death, nonfatal myocardial infarction, or nonfatal stroke
Time frame: 5 years
Cumulative incidence of all-cause death
Time frame: 5 years
Cumulative incidence of cardiac death
Time frame: 5 years
Cumulative incidence of nonfatal myocardial infarction
Time frame: 5 years
Cumulative incidence of nonfatal stroke
Time frame: 5 years
Cumulative incidence of target lesion revascularization
Time frame: 5 years
Cumulative incidence of target vessel revascularization
Time frame: 5 years
Cumulative incidence of non-target vessel revascularization
Time frame: 5 years
Cumulative incidence of definite/Probable stent thrombosis
Time frame: 5 years
Cumulative incidence of hospitalization for heart failure
Time frame: 5 years
Cumulative incidence of bleeding defined as the Bleeding Academic Research Consortium definitions type 2, 3, and 5
Time frame: 5 years
Bleeding defined as the thrombolysis In Myocardial Infarction major/minor
Time frame: 5 years
Cumulative incidence of major adverse cardiac and cerebrovascular events
All-cause death, nonfatal myocardial infarction, nonfatal stroke, or any revascularization
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.